TIFFANY HEIAR: Open Payments
NPI 1669137832 · AMES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 34 payments from 6 companies in 2025. Trend: 2023 $371 · 2024 $643 · 2025 $451
Food & beverage: $435Education: $17
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 21 | $227 |
| Regeneron Healthcare Solutions, Inc. | 5 | $86 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $18 |
| Jubilant HollisterStier LLC | 1 | $16 |
Products named: DUPIXENT, FASENRA, NEFFY, TEZSPIRE, BREZTRI, AIRSUPRA.
Industry payments across IA — which companies pay providers there.
